Sources | Names Used |
---|---|
CTRPv2 | tretinoin:navitoclax (4:1 mol/mol) |
PharmacoGx | tretinoin:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | REPS1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | CNTN4 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ACADVL | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | BRF1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | TTLL5 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | MYLK2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | PRTN3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | DUSP15 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | CDHR1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | EIF2B5 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |